Author

Stephanie Yang

Merck & Co., Inc., Rahway, NJ, USA (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alexander V. PredeusiD· 1 shared Anna O'Carroll· 1 shared Annalisa BunielloiD· 1 shared Clément ChatelainiD· 1 shared Daniel ConsidineiD· 1 shared Daniel SeatoniD· 1 shared Dániel SüvegesiD· 1 shared David G. HulcoopiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alexander V. PredeusORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The Human Pleiotropic Map of GWAS Associations and Therapeutic Implications

Yakov A. Tsepilov, Dániel Süveges, Daniel Considine, Szymon Szyszkowski, Xiangyu Jack Ge, Irene López Santiago, Polina V. Rusina, Tobi Alegbe, Vivien W. Ho, Kirill Tsukanov, Juan María Roldán‐Romero, Ines A. Smit, Helena Cornu, Laura Wiseman Harris, Kaur Alasoo, , David Ochoa

This paper analyzes 100,526 GWAS to identify pleiotropic genes and their therapeutic implications, finding that highly pleiotropic genes are associated with safety liabilities and that combining PAV support with intermediate pleiotropy improves therapeutic success.

bioRxiv · May 1, 2026 · PreprintGenomics